InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
1.20%
)
US TECH 100
17,067.60
(
1.88%
)
Dow Jones
38,503.69
(
0.69%
)
Brent Oil
87.57
(
1.34%
)
Bitcoin
66,422.73
(
-0.65%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 82
Posts 12416
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: INTL post# 428

Thursday, 03/14/2019 5:33:19 PM

Thursday, March 14, 2019 5:33:19 PM

Post# of 438
INTL, there is no upside, high risk:

Aratana Therapeutics (NASDAQ:PETX): Q4 GAAP EPS of -$0.18.
• Revenue of $4.91M (-53.1% Y/Y) misses by $1.61M.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up